Titrations of actinomycin D (AMD) with dG and with dG-dC were monitored by circular dichroism at 380 nm and 470 nm. These wavelengths are sensitive predominantly to nucleotide binding processes at the benzenoid and quinoid portions, respectively, of the phenoxazone ring of the drug chromophore [Auer, H. E., Pawlowski-Konopnicki, B. E., Chiao, Y. C. C. & Krugh, T. R. (1978), Biopolymers, 17, 1891Biopolymers, 17, -1911.J. The temperature dependence of these isotherms was analyzed by the van Fig. 1 ) is an antibiotic used in the chemotherapy of certain forms of cancer. It binds to double-helical DNA by intercalation between successive base pairs (1) with a strong preference for guanine-containing sequences (2-4). In the crystal structure of an AMD-dG2 complex (5), it was observed that the G bases are stacked diametrically opposed to one another over the benzenoid and quinoid portions, respectively, of the phenoxazone ring of the drug; the selectivity for G is apparently due to the formation of strong hydrogen bonds between the 2-amino groups of the bases and the threonyl carbonyls of the drug. Based on this structure it was proposed (6) that in native DNA a class of tight binding sites for AMD intercalation is comprised of self-complementary -dG-dC-sequences. This hypothesis has led to numerous studies of complexes formed between AMD and simple model deoxynucleotides (7-17). It has emerged that dGMP, pdG-dN (N, not C), and pdN-dG form stacked complexes with AMD in solution with the stoichimetry of AMD/dG = 1:2, whereas pdG-dC binds with the same molar ratio in a cooperative fashion forming an intercalated complex. These observations are consistent with the hypothesis of Sobell and Jain (6).
unchanged at the benzenoid site, but both values are more negative at the quinoid site. These results indicate that the additional process of binding C in the intercalated AMD4dG-dC)2 complex, with respect to the simply stacked AMD-dG2 complex, has distinctive properties at the two sites, reflecting their structural differences. The ability to resolve binding processes at the two sites by circular dichroism has permitted us to suggest assignments for the two 31p magnetic resonance lines from the phosphodiester groups observed in the AMD-.pdG-dC)2 complex [Patel, D. J (1976) Biochim. Biophys. Acta 442,98-108]. Actinomycin D (AMD, Fig. 1 ) is an antibiotic used in the chemotherapy of certain forms of cancer. It binds to double-helical DNA by intercalation between successive base pairs (1) with a strong preference for guanine-containing sequences (2) (3) (4) . In the crystal structure of an AMD-dG2 complex (5) , it was observed that the G bases are stacked diametrically opposed to one another over the benzenoid and quinoid portions, respectively, of the phenoxazone ring of the drug; the selectivity for G is apparently due to the formation of strong hydrogen bonds between the 2-amino groups of the bases and the threonyl carbonyls of the drug. Based on this structure it was proposed (6) that in native DNA a class of tight binding sites for AMD intercalation is comprised of self-complementary -dG-dC-sequences. This hypothesis has led to numerous studies of complexes formed between AMD and simple model deoxynucleotides (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) . It has emerged that dGMP, pdG-dN (N, not C), and pdN-dG form stacked complexes with AMD in solution with the stoichimetry of AMD/dG = 1:2, whereas pdG-dC binds with the same molar ratio in a cooperative fashion forming an intercalated complex. These observations are consistent with the hypothesis of Sobell and Jain (6) .
We have recently been studying the properties of AMDdeoxynucleotide complexes by using circular dichroism (CD) spectroscopy (18, 19) . Based on differing spectral responses observed under various experimental conditions, we concluded that the broad, relatively featureless absorption band of AMD centered at 440 nm is in fact comprised of three electronic transitions. One, occurring at about 370 nm, is localized to a large degree on the benzenoid section of the phenoxazone ring, whereas a second, located at about 490 nm, is predominantly centered on the quinoid portion of the chromophore. These wavelengths monitor nucleotide binding processes of high and low affinity, respectively. The third transition, located in the region of the absorption maximum at 425-440 nm, is more extensively delocalized across the entire chromophore, and therefore it presents an optical mixture of binding processes at both sites. Most studies reported in the literature have been carried out in the vicinity of this absorption maximum because the greatest sensitivity to the formation of complexes is found there.
Our studies indicate that detailed comparisons of nucleotide binding to the benzenoid and quinoid sites of AMD can be conveniently carried out in dilute solutions by using CD spectroscopy. This contrasts with other methods, such as NMR spectroscopy, that require high drug concentration, because under such conditions the ratio of concentrations of drug to free nucleotide is not propitious for the resolution of the two binding processes. As the first application of this new potential, we report here a comparative study of the binding isotherms for dG and dG-dC monitored at 380 nm and 470 nm. We used the latter wavelength instead of 490 nm in order to attain sufficient spectral sensitivity for the titration profiles. We examined the temperature dependence of these titration curves in order to obtain thermodynamic parameters for each binding process. The two binding sites were found to manifest readily distinguishable properties, which may be anticipated from the difference in their chemical constitution.
MATERIALS AND METHODS AMD (Grade I) and dGMP were from Sigma. dG and dG-dC were purchased from P-L Biochemicals. Solutions were prepared in 5 mM potassium phosphate, pH 7. Experimental procedures were similar to those previously described (19) . Initial AMD concentrations were [20] [21] [22] [23] [24] [25] ,gM, at which spectral complications arising from dimers of free AMD could be avoided. Under these conditions of high dilution, sufficient spectral sensitivity to the changes occurring at both wavelengths was attained by the use of a jacketed 4.00-cm cell. The temperature was measured with a calibrated YSI telethermometer probe inserted directly into the cell.
RESULTS
The CD spectrum of monomeric AMD displays a negative extremum at 370 nm and weak negative ellipticity centered at 445 nm (17) (18) (19) (20) (21) (22) (23) (24) . Upon complex formation of AMD with deoxynucleotides, the 370-nm band intensifies and shifts slightly to the red. Titration with dGMP produces an intense positive
The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 extremum at 445 nm with a long tail extending to 550 nm. The addition of pdG-dC to a solution of AMD leads to the formation of a weak negative band at 470 nm (17, 19) .
dG. CD spectra of the complex formed by dG and AMD closely resemble those reported for the dGMP-AMD adduct (19) [1] Van't Hoff plots of the results for dG are shown in Fig. 3 . The values of AH and AS are presented in Table 1 . They may be compared with the results of earlier studies (25) (26) (27) (28) (Fig. 4) action between the binding of the two nucleotide molecules diminishes with increased temperature. This is not in accord with earlier studies, in which complete cooperativity was reported at 8° (17) and-at 25°(10). The curve for 470 nm at 21.30 passed through negative values Of AOl/AOmax at low nucleotide concentrations (Fig. 4) . A similar but less pronounced effect was observed at 15.20, but not at 8.30. Because formation of the AMD-(dG-dC)2 complex led to enhanced negative ellipticity at this wavelength, a negative fractional change arose from a positive deflection of the CD amplitude in this portion of the titration. The CD spectrum of the AMD-(dGMP)2 complex is positive in this region of the spectrum and has a somewhat greater intensity.than does the negative extremem of the AMD-(dG-dC)2 complex (19, 21).
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O. Therefore, this effect may arise from the formation of a binary AMD-dG-dC complex in which the G is stacked at the quinoid binding site, and the C is probably not stacked on the opposite face of the phenoxazone ring. This binary complex could have existed early in the titration, at which time a significant fraction of the benzenoid sites would have remained free. As the concentration of added dinucleotide is increased, the population of this binary species is expected to decline because it should pass to the ternary complex. Specifically, at Al0/ A0max near 0.5 on the 470-nm curve, little or no binary complex is expected to remain, so that this point on the binding isotherm should accurately reflect the half-saturation point P1/2.
Values of Ka were obtained at each wavelength and temperature, as outlined above for the dG titrations. Van't Hoff plots prepared from the results are presented in Fig. 5 , and the values of AH and AS are given in Table 1 . The values of AH and AS manifest different trends at the two binding sites: no changes occurred at the benzenoid site with respect to binding dG, whereas complex formation with dG-dC at the quinoid site was more exothermic and led to a more negative value of AS than was found with dG.
DISCUSSION
The circular dichroic isotherms obtained in this work monitor the binding of deoxynucleotides by AMD in a way governed by the optical properties of the phenoxazone chromophore. It has been noted that the electronic transitions used to follow these titrations resolve the binding processes at the two binding sites in an imperfect fashion (19) . That is, Xb(380 nm) and Xq(470 nm) do not reflect exclusively nucleotide binding at the benzenoid and quinoid sites, respectively. Rather, each contains contributions from the second process.
The binding of two nucleotide molecules to the drug may be depicted as follows: NA A NA AN ;;~K Kb K is a cooperativity parameter which is set equal to unity in the [2] Biochemistry: Auer and Thompson absence of cooperative effects. Because the monitoring wavelengths do not resolve the binding processes in a perfect fashion, the saturation curve at each wavelength describes the optical contributions manifested at the wavelength in question due to complex formation at both binding sites. The fraction of the drug with a given site occupied is taken as the sum of the fractions of singly and doubly liganded species obtained by following the upper or lower path of scheme [2] , respectively.
We attempted to fit this model to titrations of AMD with dGMP which were also studied during the course of this work, using the MLAB curve fitting system (29) operating on a DEC10 computer. As noted above, the 38nm titrations at the lowest three temperatures of the four temperatures examined were biphasic. Moderate success was achieved in fitting these data. Analysis of the dG-dC titrations by this model, however, did not produce convergence. This suggests that the model may be inappropriate, perhaps in the way the spectroscopic interactions between the binding sites were treated. No other models were devised for analysis. Plotting biphasic titration curves according to the Benesi-Hildebrand equation (30) yields negative intercepts, demonstrating that this procedure is also inapplicable. For these reasons we have analyzed our results according to Eq. [1] . It must be recalled (19) that, because the optical resolution of the binding processes monitored at the two wavelengths is imperfect, the distinctions in thermodynamic properties found here represent only partial approaches to the correct values.
The thermodynamic parameters for reaction with the deoxynucleotides studied in this work (Table 1) show different trends at the two nucleotide binding sites of the drug. At the benzenoid site the values of both AH and AS remain essentially unchanged upon passing from the stacking reaction of dG to the intercalation process of dG-dC. The reaction of dG-dC at the quinoid site, however, is more exothermic and leads to a greater decrease in entropy than does complex formation with dG. The differing patterns in the thermodynamic parameters cannot be attributed to contributions from the cooperativity of the binding of the two dG-dC molecules. This originates in the hydrogen bonding between the G-C base pairs. It is likely to be exothermic and to have the same intensity for binding at both sites; indeed it is not easy to assign one or another set of hydrogen bonds to a given binding site.
The distinctions in behavior between the binding sites must rather be sought in their chemical differences. The primary distinction between the binding of dG and of dG-dC is thought to be the stacking of C on the face of the phenoxazone ring opposite to that on which G is bound (12) (13) (14) (15) . Van der Waals contributions to the enthalpy of this process will be exothermic at both binding sites. An endothermic contribution at the benzenoid site, which would compensate the Van der Waals effect and account for the absence of a change in the enthalpy, could come from unfavorable interactions between permanent dipoles of C and the benzenoid portion of the drug chromophore. At the quinoid site, which is more polar in character, these dipolar interactions could be more favorable. There exists in addition the possibility that a water-bridged hydrogen bond, albeit weak, could form between the 2-amino group of the phenoxazone ring and an oxygen from the phosphate of the dinucleoside monophosphate (6) . No such interaction is possible at the benzenoid site. Changes in the values of AS are less clearly understood.
Our experiments on the binding of dG-dC show that complex formation at the quinoid site becomes progressively weaker with respect to that at the benzenoid site as the temperature is raised. The rate constant for association of the AMD-(pdG-dC)2 complex is quite large and not likely to be strongly dependent on temperature, whereas the dissociation rate constant is small, characteristic of a significant energy of activation (17) . Therefore the relative destabilization at the quinoid site with increasing temperature probably comes about by the enhancement of the dissociation rate constant rather than by a decrease in the rate of formation of the complex. Less drastic effects of temperature are proposed for the benzenoid site. In 31p magnetic resonance studies of the AMD-(pdG-dC)2 complex, two peaks were resolved for the phosphodiester bridges of the two dinucleotides, at 1.905 ppm and 2.465 ppm upfield from trimethylphosphate (15) . The former resonance was broadened, indicating a shortened lifetime, at lower temperature than was the latter. Our results suggest that the 1.905-ppm phosphodiester resonance be assigned to the dinucleotide stacked at the quinoid site, and the 2.465-ppm peak to that complexed at the benzenoid site. In proton magnetic resonance experiments on the same system, Patel also distinguished two lines arising from the guanine N1H protons engaged in basepairing hydrogen bonds with cytosine (15) . These were found to exchange with the H20 solvent to different extents as the temperature was increased. His assignments of these resonances are in accord with our observations.
